However, there was limited data on other parameters, such as hemoglobin A1c levels, which hindered the evaluation of myonectin as a potential biomarker for prediabetes or diabetes screening [14,47], as well as exercise prescription. The gene discussed is ERFE; the disease is prediabetes syndrome.